Drug Policy

How is Kaiser Permanente different from other health plans when it comes to prescription drugs?

Research Round Up: Biosimilar Medications are Safe and Effective

Biosimilars at Kaiser Permanente: Lessons in successfully reducing spending on prescription drugs

Want to lower drug prices? Reform the U.S. patent system

Preserving and bolstering the necessary tools to promote insulin affordability

Publications from PORTAL

Restoring Provider Confidence In FDA-Approved Drugs

Evolving nature of evidence required by FDA to approve new drugs

Drug policy 101: Kaiser Permanente’s Approach to Pharmaceutical Detailing

Building a bigger table for a more equitable drug development system